Search for content and authors |
Evaluation of proliferation and cellular death of A375 cell line in the presence of HDACs inhibitors |
Ewa Chodurek , Arkadiusz Orchel , Natalia Gawlik , Anna Kulczycka , Arkadiusz R. Gruchlik , Zofia Dzierżewicz |
Department of Biopharmacy, Medical University of Silesia, Narcyzów 1, Sosnowiec 41-200, Poland |
Abstract |
Inhibitors of histone deacetylases (HDACs) are a group of compounds displaying clear anticancer activity. They have been shown to inhibit proliferation, induce apoptosis and augment differentiation in a variety of tumour cells in vitro. Valproic acid (VPA), a well known antiepileptic drug, has been shown to inhibit HDACs in some transformed cell lines. Several studies confirmed the influence of VPA on proliferation, apoptosis and differentiation processes in malignant cells. Besides, its antitumor properties include the inhibition of angiogenesis and metastasis. In melanoma cells VPA induced the cell cycle arrest in G1 phase as well as apoptosis. This effect was associated with up-regulation of P16 protein – a cell cycle inhibitor. Generally, VPA is considered as a candidate drug useful both in the chemotherapy of advanced neoplasias and chemoprevention or control of residual minimal disease. Clinical trials included phase I/II study of the therapy with VPA combined standard chemoimmunotherapy of patients suffering from advanced stage melanoma. |
Legal notice |
|
Related papers |
Presentation: Poster at VII Multidyscyplinarna Konferencja Nauki o Leku, by Ewa ChodurekSee On-line Journal of VII Multidyscyplinarna Konferencja Nauki o Leku Submitted: 2010-03-15 11:01 Revised: 2010-03-15 11:01 |